Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

CYTOO's Motility Plates to Study Cell Migration to be Launched at American Society for Cell Biology (ASCB)

Published: Monday, December 03, 2012
Last Updated: Monday, December 03, 2012
Bookmark and Share
CYTOO S.A. will launch the CYTOOplates Motility, based on CYTOO’s 2D+ Cell Culture Platform with its adhesive micropatterns, at the ASCB 2012 Annual meeting on December 15-19, 2012 in San Francisco, USA.

After sponsoring last year’s “World Cell Race”, showcased at ASCB 2011 with huge success, CYTOO returns to ASCB 2012 to launch a new product to study cell migration for screening applications in both oncology and drug discovery.

“The objective of the first World Cell Race was to perform a large-scale comparison of cell motility across many different adherent cell types under standardized conditions. Many contestants and laboratories over the world proposed their cells as competitors, and this collaborative competition1 demonstrated how fun and serious science can be mixed”, commented Alexandra Fuchs, COO of CYTOO.

“We were delighted to participate and design a product to make this race a success. After the World Cell Race, the success of our CYTOOchips Motility was undeniable, as they provide a perfect tool for studying cell migration, showing characteristics closer to those found in vivo². We will celebrate the first anniversary of the WCR with the launch of our CYTOOplates Motility in a standard microplate format.”

CYTOOplates Motility feature adhesive tracks of 4 different widths from 2.5 to 20 μm allowing a wide range of applications including single vs collective cell migration, and cell pairing ”, explained Constantin Nelep, Sr. Product Manager of CYTOO. “We have also seen our Motility products used in other application areas, such as directional neurite outgrowth assays.”

During ASCB 2012 meeting, CYTOO will also present the company’s 2D+ Cell Culture Platform, that was launched in July. Based on the use of adhesive micropatterns to guide cell architecture and behavior in culture, this technology contrasts with traditional 2D culture where cells spread and move in an uncontrolled manner, introducing a considerable but unnoticed variability in cell function. By defining the 2D topology of cell adhesion, 2D+ Technology enables the fine control of the spreading and 3D shape of cultured cells in single- or multi-cellular configurations, resulting in control of cell contractility, cell polarity, organelle positioning, or cell division axis.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Olivier Pasquier Joins CYTOO as Chief Commercial Officer
Olivier Pasquier first graduated from the French University Nice-Sophia Antipolis in molecular biology. He then completed his background with a marketing MBA from ESCP Europe.
Monday, March 18, 2013
Scientific News
New Autism Blood Biomarker Identified
Researchers at UT Southwestern Medical Center have identified a blood biomarker that may aid in earlier diagnosis of children with autism spectrum disorder, or ASD.
It’s Now Easier To Go With The Flow
Rice University tool simplifies comparison of flow cytometry data for laboratories.
FNIH Launches Project to Evaluate Biomarkers in Cancer Patients
Company has announced that it has launched a new project to evaluate the effectiveness of liquid biopsies as biomarkers in colorectal cancer patients.
Drugs that May Combat Deadly Antibiotic-Resistant Bacteria Uncovered
Study identifies 79 compounds that inhibit carbapenem-resistant Enterobacteriaceae (CRE).
Making Precision Medicine a Reality
Researchers are one step closer to understanding the genetic and biological basis of diseases like cancer, diabetes, Alzheimer’s and rheumatoid arthritis – and identifying new drug targets and therapies.
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!